Diagnostic Blood Biomarkers in Alzheimer’s Disease

Diagnostic Blood Biomarkers in Alzheimer’s Disease

Potential biomarkers for Alzheimer’s disease (AD) include amyloid β<sub>1–42</sub> (Aβ<sub>1–42</sub>), t-Tau, p-Tau<sub>181</sub>, neurofilament light chain (NFL), and neuroimaging biomarkers. Their combined use is useful for diagnosing and monitoring the progres...

Full description

Bibliographic Details
Main Authors:	Jung Eun Park, Tamil Iniyan Gunasekaran, Yeong Hee Cho, Seong-Min Choi, Min-Kyung Song, Soo Hyun Cho, Jahae Kim, Ho-Chun Song, Kyu Yeong Choi, Jang Jae Lee, Zee-Yong Park, Woo Keun Song, Han-Seong Jeong, Kun Ho Lee, Jung Sup Lee, Byeong C. Kim
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Biomedicines
Subjects:	Alzheimer’s disease plasma biomarkers NFL Aβ<sub>1–42</sub> combinatorial biomarkers
Online Access:	https://www.mdpi.com/2227-9059/10/1/169

Similar Items

Preliminary study of neurofilament light chain as a biomarker for hypoxia-induced neuronal injury in dogs
by: Taesik Yun, et al.
Published: (2023-10-01)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
by: Jung Eun Park, et al.
Published: (2019-03-01)

The evaluation of serum brain‐derived neurotrophic factor and neurofilament light chain levels in patients with obstructive sleep apnea syndrome
by: Burak Arslan, et al.
Published: (2021-12-01)

Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
by: Jung Eun Park, et al.
Published: (2021-01-01)

Association between neurofilament light chain concentration and lesion size in dogs with meningoencephalitis of unknown origin
by: Taesik Yun, et al.
Published: (2023-07-01)

Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria
by: Daniela Kern, et al.
Published: (2022-03-01)

Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study
by: Marie Süße, et al.
Published: (2024-04-01)

Evaluation of serum neurofilament light chain and glial fibrillary acidic protein in the diagnosis of Alzheimer’s disease
by: Tangni Fang, et al.
Published: (2024-01-01)

Plasma neurofilament light and its association with all-cause mortality risk among urban middle-aged men and women
by: May A. Beydoun, et al.
Published: (2022-06-01)

Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer’s disease
by: Tandis Parvizi, et al.
Published: (2022-08-01)

Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes
by: Matthew P. Lennol, et al.
Published: (2023-02-01)

Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trialsResearch in context
by: Amit Bar-Or, et al.
Published: (2023-07-01)

Synergistic Effects of Fe<sub>2</sub>O<sub>3</sub> Nanotube/Polyaniline Composites for an Electrochemical Supercapacitor with Enhanced Capacitance
by: Farkhod Azimov, et al.
Published: (2021-06-01)

Performance Enhancement in Powder-Fabricated Cu<sub>2</sub>(ZnSn)Se<sub>4</sub> Solar Cell by Roll Compression
by: Jaehyun Park, et al.
Published: (2023-01-01)

Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Chiara Fornari, et al.
Published: (2022-04-01)

Plasma UCHL1, GFAP, Tau, and NfL Are Not Different in Young Healthy Persons With Mild COVID-19 Symptoms Early in the Pandemic: A Pilot Study
by: Matthew J. Rogatzki, et al.
Published: (2023-05-01)

Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases
by: Isabella Zanella, et al.
Published: (2022-05-01)

Extracellular Vesicle Proteins and MicroRNAs Are Linked to Chronic Post-Traumatic Stress Disorder Symptoms in Service Members and Veterans With Mild Traumatic Brain Injury
by: Vivian A. Guedes, et al.
Published: (2021-10-01)

Fabrication and Characterization of Al<sub>2</sub>O<sub>3</sub>-Siloxane Composite Thermal Pads for Thermal Interface Materials
by: Seul-Ki Kim, et al.
Published: (2024-02-01)

Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
by: Jia-Hung Chen, et al.
Published: (2021-10-01)

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
by: Christoph Kessler, et al.
Published: (2022-11-01)

Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample
by: Maya Arvidsson Rådestig, et al.
Published: (2023-03-01)

Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?
by: Dominique Comeau, et al.
Published: (2023-07-01)

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
by: Marie Dreger, et al.
Published: (2021-04-01)

Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
by: Eun Hyun Seo, et al.
Published: (2021-10-01)

CoFe<sub>2</sub>O<sub>4</sub> on Mica Substrate as Flexible Ethanol Gas Sensor in Self-Heating Mode
by: Jong Hun Kim, et al.
Published: (2024-03-01)

Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications
by: Daniel Sanchez-Tejerina, et al.
Published: (2023-04-01)

Controlled Crystallinity of a Sn-Doped α-Ga<sub>2</sub>O<sub>3</sub> Epilayer Using Rapidly Annealed Double Buffer Layers
by: Kyoung-Ho Kim, et al.
Published: (2024-01-01)

Polyol-Mediated Synthesis of V<sub>2</sub>O<sub>5</sub>–WO<sub>3</sub>/TiO<sub>2</sub> Catalysts for Low-Temperature Selective Catalytic Reduction with Ammonia
by: Min Seong Lee, et al.
Published: (2022-10-01)

CO<sub>2</sub> Sorption and Regeneration Properties of K<sub>2</sub>CO<sub>3</sub>/Al<sub>2</sub>O<sub>3</sub>-Based Sorbent at High Pressure and Moderate Temperature
by: Do-Yeong Ryu, et al.
Published: (2022-03-01)

Potential Joint Protective and Anti-Inflammatory Effects of Integrin α<sub>v</sub>β<sub>3</sub> in IL-1β-Treated Chondrocytes Cells
by: Hun Hwan Kim, et al.
Published: (2023-10-01)

The Impact of Vertical Eddy Diffusivity Changes in the CMAQ Model on PM<sub>2.5</sub> Concentration Variations in Northeast Asia: Focusing on the Seoul Metropolitan Area
by: Dong-Ju Kim, et al.
Published: (2024-03-01)

Effects of Hydrogen Gas Inhalation on Community-Dwelling Adults of Various Ages: A Single-Arm, Open-Label, Prospective Clinical Trial
by: Md. Habibur Rahman, et al.
Published: (2023-06-01)

A new metabolomic assay to examine inflammation and redox pathways following LPS challenge
by: Suh Jung H, et al.
Published: (2012-10-01)

Antibody Profiling: Kinetics with Native Biomarkers for Diagnostic Assay and Drug Developments
by: Ute Jucknischke, et al.
Published: (2023-12-01)

Cerebral Biomarkers and Blood-Brain Barrier Integrity in Preeclampsia
by: Therese Friis, et al.
Published: (2022-02-01)

Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting
by: Michael Seiberl, et al.
Published: (2023-02-01)

Optimization of a LaNiO<sub>3</sub> Bottom Electrode for Flexible Pb(Zr,Ti)O<sub>3</sub> Film-Based Ferroelectric Random Access Memory Applications
by: Yeong Uk Choi, et al.
Published: (2023-11-01)

A Novel Approach to Assessing Light Extinction with Decade-Long Observations of Chemical and Optical Properties in Seoul, South Korea
by: Seung-Myung Park, et al.
Published: (2024-03-01)

Preparation and Properties of Poly(imide-siloxane) Copolymer Composite Films with Micro-Al<sub>2</sub>O<sub>3</sub> Particles
by: Ju-Young Choi, et al.
Published: (2019-02-01)